Published: 12 December 2013
Publications
Quarterly Summary of Medsafe Early Warning System Communications
Prescriber Update 34(4): 49
December 2013
The early warning system provides current and historical information on safety concerns for medicines and medical devices. These warnings are intended to help consumers and healthcare professionals make informed decisions about their use of medicines and medical devices.
More information about the early warning system can be found on the Medsafe website (www.medsafe.govt.nz/safety/EWS/EWS.asp).
Date | Communication | Topic |
---|---|---|
4 October 2013 | Alert | Pradaxa (dabigatran etexilate) and oesophageal ulcer |
1 November 2013 | Monitoring | Statins and a possible risk of acute kidney injury (without rhabdomyolysis) |
1 November 2013 | Monitoring | Ornidazole and adverse effects on the eye |
11 November 2013 | Alert | m-Captopril tables 12.5mg, 25mg, 50mg, 100mg - Manufacturing Issues |
12 November 2013 | Alert | Discontinuation of oral ketoconazole (Nizoral) 200mg tablets |
12 November 2013 | Monitoring | Update: Hydroxyethyl starch solutions (Voluven, Volulyte 6%) associated with increased risk of mortality and renal impairment |
If you would like to receive Medsafe's early warning communications you
can subscribe at www.medsafe.govt.nz/profs/subscribe.asp